Augmedix, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 12.68 million compared to USD 8.75 million a year ago. Net loss was USD 4.49 million compared to USD 5.6 million a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.799 USD | +3.63% | +1.94% | -86.47% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.47% | 37.75M | |
+17.83% | 71.68B | |
+8.06% | 17.68B | |
+13.72% | 14.3B | |
+16.40% | 13.18B | |
+12.53% | 9.86B | |
-23.74% | 6.55B | |
-8.07% | 5.7B | |
+4.58% | 5.31B | |
+8.52% | 4.8B |
- Stock Market
- Equities
- AUGX Stock
- News Augmedix, Inc.
- Augmedix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023